Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11733)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2022 (publication date) through Sep 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mohan V, Wangnoo S, Das S, Dhediya R, Gaurav K. Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review. World J Diabetes 2022; 13(12): 1168-1183 [PMID: 36578872 DOI: 10.4239/wjd.v13.i12.1168] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i12/1168.htm |
| Number | Citing Articles |
| 1 |
Rifika Bansal, Ravi Kant, Yogesh Bahurupi, Ashwarya Gupta. Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review. Indian Journal of Endocrinology and Metabolism 2025; 29(3): 260 doi: 10.4103/ijem.ijem_372_24
|
| 2 |
Alka Bishnoi, Amitabh Sur, Bensley Gonsalves, Bhawna Atri, Soumik Goswami, Venkatesan Ravindranath, Vivek Patel, Hiren Prajapati, Disha Shah. Taking a Closer Look at Gliclazide – Benefits Beyond Glycemic Control. International Journal of Diabetes and Technology 2025; 4(3): 49 doi: 10.4103/ijdt.ijdt_10_25
|